Wings Therapeutics
Berkeley, US · Founded 2019 · Delaware corporation
Founders & leadership
MP
Mark P. de SouzaNamed on SEC filing
GP
Gerard PlatenburgNamed on SEC filing
HL
Hal LandyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2019
▶$1.5MraisedJun 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJun 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark P. de SouzaExecutive Officer, Director
- Gerard PlatenburgDirector
- Hal LandyExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.5M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Wings Therapeutics raised?
- Wings Therapeutics has disclosed $1.5M raised across 1 round.
- Where is Wings Therapeutics headquartered?
- Wings Therapeutics is headquartered in Berkeley, US.